Investigating the role of androgen receptor signalling inoestrogen receptor positive breast cancer
Başlık çevirisi mevcut değil.
- Tez No: 760331
- Danışmanlar: DR. GREG BROOKE
- Tez Türü: Doktora
- Konular: Göğüs Cerrahisi, Onkoloji, Thoracic Surgery, Oncology
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2021
- Dil: İngilizce
- Üniversite: University of Essex
- Enstitü: Yurtdışı Enstitü
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 287
Özet
Özet yok.
Özet (Çeviri)
Breast cancer (BrCa) is the most common cancer in the UK. The majority of BrCa cases are oestrogen receptor α (ERα) positive, and sensitive to endocrine therapies (antioestrogens and aromatase inhibitors). Endocrine therapies for ERα-positive disease are effective initially, but often fail and the disease progresses to the endocrine resistant stage, for which few therapeutic options exist. The androgen receptor (AR) is the most commonly expressed steroid receptor in BrCa, occurring in up to 90% of cases. AR expression in early disease is associated with positive prognostic outcomes in ERα-positive disease. However, AR expression has also been associated with endocrine resistance. These different roles of AR could be because of the changes in the crosstalk between AR and ERα at different stages of the disease, and these changes might have important implications in endocrine resistance. Hence, this study aimed to understand the role of AR in ERα-positive disease and how this crosstalk is affected by antioestrogen treatments. Crosstalk studies between the two steroid receptors in ERα-positive cell lines (MCF7, T47D) demonstrated that AR-ERα crosstalk is inhibitory, and that antioestrogens can reverse the inhibitory effect of ERα upon AR target gene expression. This increase in AR activity appears to be as a result of enhanced AR expression and DNA binding. Importantly, the AR was also found to reverse the inhibitory effect of the antioestrogen fulvestrant on BrCa proliferation. RNA-Seq analysis showed that the AR induces pathways linked to cellular proliferation, and becomes transcriptionally more active when ERα is inhibited by fulvestrant. Analysis of the transcriptional activity of AR mutants, identified in BrCa patients, showed that some mutations affect the transcriptional activity of the AR, and AR-ERα crosstalk. The data demonstrates that the role of the AR in BrCa is complex and that targeting both receptors may have a more clinically favourable outcome, and reduce therapy resistance in patients.
Benzer Tezler
- Prostat kanseri gelişiminde androjenlerin oksidatif stres kontrolündeki rolünün araştırılması
Investigating the role of oxidative stress control of androgens onto development of prostate cancer
NURŞAH ERTUNÇ
Yüksek Lisans
Türkçe
2015
BiyoteknolojiEge ÜniversitesiBiyoteknoloji Ana Bilim Dalı
PROF. DR. KEMAL SAMİ KORKMAZ
- Prostat kanser hücrelerinde çift sarmal kırık onarımının androjen ile değişiminin araştırılması
Investigating androgen-mediated alteration of double strand break repair response in prostate cancer
BESRA ÖZMEN
Yüksek Lisans
Türkçe
2012
BiyolojiEge ÜniversitesiBiyoteknoloji Ana Bilim Dalı
PROF. DR. KEMAL SAMİ KORKMAZ
- CDK inhibitörlerinin mTOR susturması gerçekleştirilen LNCaP, DU145 ve PC3 prostat kanseri hücrelerinde terapotik etkisinin incelenmesi
Investigation of therapeutic effects of the CDK inhibitors on mTOR-silenced LNCaP, DU145 and PC3 prostate cancer cells
ÇAĞRI GÜMÜŞKAPTAN
Yüksek Lisans
Türkçe
2015
Biyokimyaİstanbul Kültür ÜniversitesiMoleküler Biyoloji ve Genetik Ana Bilim Dalı
DOÇ. DR. ELİF DAMLA ARISAN
- Prostat hücrelerinde EFS'nin androjen düzenlenmesinin araştırılması
Investigation of the androgen regulation of EFS in prostate cell
HASİNE YEL
Yüksek Lisans
Türkçe
2016
Moleküler TıpHarran ÜniversitesiBiyoloji Ana Bilim Dalı
YRD. DOÇ. DR. İSMAİL KOYUNCU
- Androjen duyarlı ve kastrasyona dirençli prostat kanseri hücre serilerinde androjen reseptörünü hedef alan miRNA' nın belirlenmesi ile hedef aldığı diğer genlerle gelişen direnç mekanizmasının incelenmesi
Defining mirna targeting androgen receptor and this miRNA's target genes with investigation of developed resistance mechanism in androgen sensitive and castration resistant prostate cancer cell lines
ÇAĞDAŞ AKTAN